INITIATOR PHARMA A/SINITIATOR PHARMA A/SINITIATOR PHARMA A/S

INITIATOR PHARMA A/S

No trades
See on Supercharts

INIT fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. Its portfolio consists of IPED2015, represents a novel treatment paradigm for the treatment of organic erectile dysfunction (ED); and IP2018, a drug candidate for the treatment of psychogenic ED and depression. The company was founded by Claus Elsborg Olesen, Dan Peters, Ulf Simonsen, and Mikael Sondergaard Thomsen in 2016 and is headquartered in Copenhagen, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

INIT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company